Open AccessP05: DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 POLLUX TRIAL
Author(s) -
Dimopoulos MA,
Oriol A,
Nahi H,
SanMiguel J,
Bahlis NJ,
Usmani SZ,
Rabin N,
Orlowski RZ,
Suzuki K,
Plesner T,
Yoon SS,
Ben Yehuda D,
Richardson PG,
Goldschmidt H,
Reece D,
Ahmadi T,
Qin X,
Garvin Mayo W,
Gai X,
Carey J,
Carson R,
Moreau P
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000829592.26407.09
Subject(s) - daratumumab , medicine , lenalidomide , multiple myeloma , hematology , oncology , family medicine